INTUITIVE SURGICAL INC (ISRG) Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Medical - Instruments & Supplies
Intuitive Surgical, Inc. NASDAQ:ISRG Healthcare · Medical - Instruments & Supplies
Mkt Cap $152.62B
Vol 0
$ Vol 0
RVOL 0
Earnings 0
Press Release ● Critical ⚠ 3
Intuitive Announces Third Quarter Earnings
Intuitive reported Q3 2026 revenue of $3.05 billion, up 22% year-over-year, with non-GAAP EPS of $3.00 versus $2.40 a year ago, driven by ~15% procedure growth and 546 da Vinci system placements.
Results included a one-time $450 million pre-tax charge to settle the previously disclosed da Vinci antitrust class action (no admission of liability), which cut GAAP EPS to $1.49; the settlement still requires court approval.
The company also repurchased 7.8 million shares for $2.94 billion in the quarter, leaving $6.80 billion in cash and investments, and guided FY26 da Vinci procedure growth of ~14-15% with non-GAAP gross margin of 68.7-69.3% including an estimated 0.9% tariff impact.
• 12d ago AI analysis › Press Release
Intuitive announces expanded indication for da Vinci SP in Europe
Intuitive received CE mark approval for transvaginal gynecologic procedures on the da Vinci SP surgical system in Europe, which the company describes as a world's-first indication for the single-port platform.
The approval adds to SP's existing CE-marked applications in Europe — endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast procedures — and SP is also approved in the US, Japan, and Korea.
Intuitive's European commercial president framed the milestone as expanding access to less invasive options in women's health, where the company cites strong SP adoption and support from more than 1,000 peer-reviewed publications.
• 1mo ago AI analysis › Press Release
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Intuitive published a landmark meta-analysis in Annals of Surgery Open showing statistically significant improvements in patient outcomes for da Vinci surgery versus laparoscopic and open approaches across 13 benign conditions.
The study analyzed data from over 14 million procedures performed in 32 countries, finding da Vinci surgery was associated with lower odds of conversion to open surgery, reduced blood transfusions, shorter hospital stays, and faster return to work.
More than 21 million patients have been operated on using the da Vinci system, with 3.1 million procedures performed in 2025 alone.
• 1mo ago AI analysis › Press Release
Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
Honeywell Technologies is briefly mentioned in an AINewsWire editorial as having commercially launched Experion Operations Assistant, an AI-powered solution for monitoring plant performance.
The article notes that the solution is built on Honeywell's Experion PKS platform and designed to help operators forecast critical scenarios.
This content is part of a paid profile primarily focused on Nightfood Holdings, with Honeywell cited only as a contextual peer in the AI and industrial automation sectors.
• 2mo ago AI analysis › Press Release
Intuitive Expands Manufacturing Footprint in Asia Pacific with New Facility in Penang, Malaysia
Intuitive announced a lease agreement for a new 316,000-square-foot manufacturing facility in Penang, Malaysia, to support growing demand in Asia Pacific.
The site is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032, focusing on surgical instruments and electromechanical devices for the da Vinci system.
Management emphasized this as a long-term investment to scale global operations and improve supply chain resilience.
• 2mo ago AI analysis › Press Release
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
Intuitive announced a collaboration with Deion 'Coach Prime' Sanders to raise patient awareness of surgical options, specifically the company's da Vinci robotic-assisted surgery systems.
Sanders, who underwent robotic surgery for bladder cancer in 2025, will share his experience to encourage patients to engage in informed discussions with their physicians about surgical choices.
The company noted that more than 20 million patients worldwide have been operated on by surgeons using da Vinci systems.
• 3mo ago AI analysis › Press Release ⚠ 2
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
Intuitive outlined its strategic vision for AI in surgical care at the Society of Robotic Surgery annual conference, detailing a five-layer framework ranging from data collection to supervised autonomy.
The company showcased its data foundation of over 20 million da Vinci procedures and conducted a live telesurgery demonstration connecting Sunnyvale and Atlanta using the da Vinci 5 system.
Management emphasized that while the telesurgery software demonstrates potential for expanding access to specialized care, it remains in development and is not currently approved for commercial sale.
• 3mo ago AI analysis › Press Release ● Major ⚠ 1
Intuitive Announces Second Quarter Earnings
Intuitive reported Q2 revenue of $2.89 billion, up 19% year-over-year, driven by a 16% increase in worldwide procedures including 36% growth for Ion systems.
The company placed 468 da Vinci surgical systems during the quarter, including 246 of the next-generation da Vinci 5, bringing the total installed base to 11,710.
For the full year 2026, the company projects da Vinci procedure growth of 13.5% to 15.5% and repurchased $380 million of common stock.
• 3mo ago AI analysis › Press Release
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
Intuitive Surgical promoted Taylor Patton to Chief Commercial and Marketing Officer, effective July 1.
Patton succeeds Henry Charlton, who will transition to Senior Vice President of Global Business Operations to support the handover.
CEO Dave Rosa highlighted Patton’s two-decade tenure and experience launching the Ion platform as key qualifications for the new role.
• 5mo ago AI analysis › Press Release
Intuitive Announces Innovations to Advance Quintuple Aim
Intuitive Surgical announced over 100 updates to its da Vinci 5 platform, including telepresence enhancements, mobile login, and new simulation exercises for SimNow 2.
The company extended the usable life of Force Feedback instruments from six to 15 uses, aiming to lower total cost of care while maintaining safety and precision.
Intuitive reported that more than 1,400 da Vinci 5 systems are installed globally, with actual uptime exceeding 99% against a 98% guarantee.
• 5mo ago AI analysis › Press Release ● Major
Intuitive Announces First Quarter Earnings
Intuitive reported Q1 2026 revenue of $2.77 billion, up 23% year-over-year, driven by a 17% increase in worldwide procedures and higher system placements.
GAAP net income rose to $822 million, or $2.28 per diluted share, while non-GAAP EPS reached $2.50, supported by a 23% increase in instruments and accessories revenue.
The company returned $1.1 billion to shareholders through buybacks and raised its 2026 procedure growth outlook to a range of 13.5% to 15.5%.
• 6mo ago AI analysis › Press Release
SurGenTec Secures FDA 510(k) Clearance for TiLink™ SI joint fusion- Now Navigation Compatible
businesswire.com • 6mo ago Press Release
Intuitive Expands Investment and Footprint in Europe
globenewswire.com • 8mo ago